/ Active, not recruitingN/AIIT Iceland Screens, Treats or Prevents Multiple Myeloma
This study will assess the benefits and harms of screening for monoclonal gammopathy of undetermined significance (MGUS). The overall and disease-specific mortality will be compared between screened and not screened participants. All individuals registered as inhabitants in Iceland and born in 1975 or earlier have been invited to participate. The hypothesis is that an early detection of multiple myeloma (MM), through follow-up of MGUS, will improve overall survival and decrease complications associated with diagnosis and treatment of MM.
100 项与 The Binding Site GmbH 相关的临床结果
0 项与 The Binding Site GmbH 相关的专利(医药)
100 项与 The Binding Site GmbH 相关的药物交易
100 项与 The Binding Site GmbH 相关的转化医学